Joint CMU-Pitt Ph.D. Program in Computational Biology

LLS Invests in Solutions to Advance Health Equity

Retrieved on: 
Friday, July 15, 2022
Research, Medicare, University, Lymphatic system, Cancer, Patient, Volunteering, Joint CMU-Pitt Ph.D. Program in Computational Biology, Solution, City, Clinical, Medicaid, Vanderbilt University Medical Center, LLS, Equity, Program, University of Colorado Denver, Adoption, Human, ET, Insurance, Hodgkin lymphoma, Beckman Research Institute, Clinical trial, Survival, Tumors of the hematopoietic and lymphoid tissues, Religion, Leukemia, Health, University of Colorado School of Medicine, Lymphoma, Color, RFP, Survivor, Health equity, Public policy, Emory University School of Medicine, Multiple myeloma, Leukemia & Lymphoma Society, Mental health, Pharmaceutical industry, Health insurance, Access

RYE BROOK, N.Y., July 15, 2022 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is dedicated to ensuring that all blood cancer patients and survivors have access to the care they need, when they need it. But for too many patients, this does not happen.

Key Points: 
  • "That's why LLS created the Equity in Access Research Program.
  • The new program is just one avenue LLS is pursuing as part of its longstanding commitment to health equity.
  • LLS issued the second Equity in Access Research Program Request for Proposals (RFP) on July 6.
  • LLS is steadfast in its commitment to serving underrepresented communities through two more programsthe LLS IMPACT Research Grants initiative and Myeloma Link which aim to promote health equity in clinical and community settings.

Union Institute & University Presents its 23rd Residency Conference & Annual Social Justice Dinner

Retrieved on: 
Tuesday, June 28, 2022
Joint CMU-Pitt Ph.D. Program in Computational Biology, Higher Learning Commission, Heart, Research, Higher, Student, Union Institute & University, Climate, Interdisciplinarity, Female, Multimedia, Social justice, Faculty, Congress, Education, Classroom, University, Social, Board of directors, Board, Conference, Knowledge, Thought, Union, Medicine, Trustee, Hope

CINCINNATI, June 28, 2022 ­­/PRNewswire/ --  On Monday, July 11, 2022, Union Institute & University's Ph.D. Program in Interdisciplinary Studies presents the 23rd Residency Conference entitled "Ecologies of Hope and Change: Confronting Environmental Injustice from Climate to the Classroom and Beyond." Like time, there never seems to be enough hope, and the conference works to create more of it. Union's current students and alumni will confront injustice in order to bring hope and change. Presenters and participants synthesize the knowledge and find new ways of thinking about their own research topic, in a true interdisciplinary style. The conference will end with Union's annual Social Justice dinner, featuring the poet, Richard Blanco.

Key Points: 
  • Program in Interdisciplinary Studies presents the 23rd Residency Conference entitled "Ecologies of Hope and Change: Confronting Environmental Injustice from Climate to the Classroom and Beyond."
  • Like time, there never seems to be enough hope, and the conference works to create more of it.
  • The conference will end with Union's annual Social Justice dinner, featuring the poet, Richard Blanco.
  • Union Institute & University Presents its 23rd Annual Social Justice Dinner, which features Richard Blanco
    Blanco wears many hats: presidential inaugural poet, memoirist, public speaker, educator, and advocate.

CytoImmune Therapeutics Appoints Renowned Oncologist and Immunologist as New Chief Executive Officer

Retrieved on: 
Wednesday, November 10, 2021
Rubius, BCMA, University, Cancer, Lung cancer, Joint CMU-Pitt Ph.D. Program in Computational Biology, Therapy, Leadership, Engineering, CEO, Knowledge, Hospital, Pfizer, GPRC5D, Acute myeloid leukemia, Einstein Medical Center Philadelphia, TCR, FLT3, NK, PSCA, Lymphatic system, Board, Immunocore, Multiple myeloma, Biotechnology, GLOBE, Pediatric Hematology and Oncology, Large-cell lung carcinoma, Board of directors, Philadelphia, Patient, Pharmaceutical industry, Medical imaging

LOS ANGELES, Nov. 10, 2021 (GLOBE NEWSWIRE) -- CytoImmune Therapeutics , a privately-held cell therapy company focused on developing natural killer (NK) immune cells to fight cancer, announces the appointment of Christina Coughlin M.D., Ph.D., as their Chief Executive Officer.

Key Points: 
  • LOS ANGELES, Nov. 10, 2021 (GLOBE NEWSWIRE) -- CytoImmune Therapeutics , a privately-held cell therapy company focused on developing natural killer (NK) immune cells to fight cancer, announces the appointment of Christina Coughlin M.D., Ph.D., as their Chief Executive Officer.
  • Dr. Coughlin joins CytoImmune from Rubius Therapeutics, Inc. where she served as the Chief Medical Officer and led the clinical development, translational medicine, and regulatory efforts in the allogeneic red cell therapy platform.
  • Prior to Rubius, Dr. Coughlin was with Tmunity Therapeutics, Inc., where she served as Chief Medical Officer and was responsible for the preclinical and clinical development of autologous CAR-T and TCR-T cellular therapies.Dr.
  • "We're pleased to welcome Dr. Coughlin as our Chief Executive Officer," said Michael Caligiuri M.D., scientific co-founder, and Chief Medical Officer at CytoImmune .

SIGKDD Honors Groundbreaking Achievements in Knowledge Discovery and Data Mining

Retrieved on: 
Friday, August 13, 2021
Cloud, Knowledge, Test, Microsoft, Data mining, Discovery, Intelligent Community Forum, Interest group, Research, Science, University of California, Represent, LinkedIn, KDD, Champaign–Urbana metropolitan area, University, Learning, University of California, Berkeley School of Information, Machine learning, Rice University, Head, Rising Star Award, SIGKDD, Champaign County, Illinois, Growth, Facebook, Significance, Volunteering, Algorithm, Economic Times Awards, ACM, Association for Computing Machinery, Association, Artificial intelligence, Data science, Student, Joint CMU-Pitt Ph.D. Program in Computational Biology, Industry, Medical device, Public relations

SINGAPORE, Aug. 13, 2021 /PRNewswire/ -- The Association for Computing Machinery (ACM) Special Interest Group on Knowledge Discovery and Data Mining (SIGKDD) today announced the recipients of the 2021 ACM SIGKDD Awards for exemplary individuals and research teams in data science, machine learning, big data and artificial intelligence (AI). Ahead of the organization's annual conference on Aug. 14-18, the awards program recognizes those who have made a lasting impact in the industry.

Key Points: 
  • "The KDD conference has long served as an international platform that showcases the most innovative research in data mining and knowledge discovery," said Wei Wang, SIGKDD chair and professor in computer science at the University of California, Los Angeles.
  • The ACM SIGKDD Innovation Award is the highest honor for technical excellence in knowledge discovery and data mining.
  • The award honors an individual or group of collaborators for outstanding contributions to professional KDD societies or society-at-large through applications of knowledge discovery and data mining.
  • "The KDD conference has been celebrating the contributors in knowledge discovery and data mining for over two decades," said Dr. Hu.